{"disease":{"id":"recurrent-or-progressive-high-grade-glioma","name":"recurrent or progressive high grade glioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06468605","title":"Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade Glioma","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Duke University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}